FDA Inspection 1101032 — PAREXEL INTERNATIONAL, Corp
The FDA completed an inspection of PAREXEL INTERNATIONAL, Corp on Aug 21, 2019 in Billerica, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Billerica, MA (United States)
Additional details
Sponsor, Contract Research Organization